Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle

—Not the Other Way Around
A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There was a peak of 1,265 trials paused or indefinitely delayed in June 2020—impacting nearly 1,000 companies. Disruptions included delayed initiation or complete withdrawal of planned trials, as well as suspended enrollment or cancellation of on-going trials. The number of disrupted trials has been falling slowly since June 2020, with most current disruptions due to other factors, such as slow enrollment.

Are Decentralized Clinical Trials Effective?

The COVID-19 pandemic has been an expensive experience, costing months of delay to over 70% of all clinical trials. In the world of clinical research, the pandemic has taught us more about what direct-to-patient trials really means, and how we can innovate to deliver better studies. Interviewing a mix of study sponsors, coordinators and investigators, it is clear that decentralized trials have been proven to deliver faster, easier and cost effective trials. 61% say decentralized trials are faster than traditional trials in, saving clients under 3 months to recruit for a study 75% say decentralized trials are better for patient

What is Decentralized Clinical Trials

Clinical Trials come in multiple flavors, including virtual, hybrid, and fully site-based trials. The impact of COVID-19 on the industry of clinical research and drug delivery has interrupted nearly 80% of the studies, which challenged the ability to conduct trials safely.This has led the industry to think of innovative ways to conduct clinical trials, including the ability for patients to conduct a clinical trial from the comfort of their home. Decentralized Trials has gained enormous momentum to help keep clinical trials moving forward, but what does that mean?Prior to COVID-19, most clinical trials happened at a doctor’s office, including the

Consideration for Device Selection in Clinical Trials

W E LCO M E TO T H E D E LV E B LO G . FPO Considering a wearable for an upcoming study? Below are items we often discuss with clients when selecting a device for their study: Study objectives (therapeutic area, the concept of interest, endpoint required, duration of the study, blinded/unblinded data, etc.) Patient centricity (ease of use, passive monitoring or active assessment, reduce the patient burden and support – patient concierge) Device characteristics (scientific evidence and validations, battery life, connectivity) Data (transfer, storage, analytics) Regulatory considerations Privacy and security How else can Delve Health help you? 1.

Apple Watch in Clinical Trials

Considering a wearable for your upcoming clinical trial?  The Apple Watch is an FDA approved Class II device with a slick, beautiful and powerful utility to help conduct a remote virtual clinical trial.  At Delve Health, we utilize the Apple Watch to collect over 20 digital endpoints across multiple therapeutic areas. Below are a few cases, where an Apple Watch is being used: Enable the early detection of atrial fibrillation and potentially improve outcomes including stroke Identify irregular heart rhythms, including for serious heart conditions such as atrial fibrillation Parkinson’s disease, in which symptoms include tremors, rigidity, slowness of movement and difficulty

Four Issues Affecting Clinical Research Teams Today

1 | Wearable Integration Remote patient monitoring is a key component within clinical research and where the probable impact of wearable integration will be the most measurable. The increased ability to remotely provide patient monitoring will soon change how clinical research teams will ultimately interact with patients. Through these sensors, clinical researchers and other study teams, will be able to better understand how a patient has been fairing at home. They will also be able to capture and collect data on patients regarding their conditions and whether or not they have experienced any adverse reactions. This real-time data capture will enable

Scroll to Top